A systematic review of the effectiveness and cost-effectiveness of palivizumab (Synagis) in the prevention of respiratory syncytial virus (RSV) infection in infants at high risk of infection
by Sue Simpson
200133 pages
University of Birmingham, Department of Public Health and Epidemiology·1 editions
Loading Description
Tags
NewBookshelves
0 readersNo users with this book on their shelves. Maybe you could be the first.
Threads
0 discussionsQuotes
0 quotesReviews
0 reviewsNo reviews yet. Add your review.
Lists
0 listsNo lists containing this book.
Purchasable Editions
1 editionsThe Amazon links are affiliate links
A systematic review of the effectiveness and cost-effectiveness of palivizumab (Synagis) in the prevention of respiratory syncytial virus (RSV) infection in infants at high risk of infection (2001)
A systematic review of the effectiveness and cost-effectiveness of palivizumab (Synagis) in the prevention of respiratory syncytial virus (RSV) infection in infants at high risk of infection (2001)
University of Birmingham, Department of Public Health and Epidemiology
University of Birmingham, Department of Public Health and Epidemiology
ISBN 10: 0704423219